Ichiba, Tomohisa
Suzuki, Masahiro
Aritake-Okada, Sayaka
Uchiyama, Makoto
Funding for this research was provided by:
Kao Corporation
Article History
Received: 13 November 2018
Accepted: 25 March 2019
First Online: 5 April 2019
Competing Interests
: Dr. M. Uchiyama has received research support from Astellas Pharma, Eisai, Meiji Seika Pharma, MSD, Taisho Pharmaceutical, Kao Corporation, and Takeda Pharmaceutical, and has consulted for Kao Corporation, Taisho Pharmaceutical and Takeda Pharmaceutical. He has also received honoraria for giving lectures and/or contributing text from Eisai, Meiji Seika Pharma, MSD, and Takeda Pharmaceutical. T. Ichiba is an employee of Kao Corporation. Dr. M. Suzuki and Dr. S. Aritake-Okada declare no potential conflict of interest.